Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.8050

-0.0380 (-4.51%)

At close: Apr 10, 2026, 4:00 PM EDT

0.8180

+0.0130 (1.61%)

After-hours: Apr 10, 2026, 7:33 PM EDT

Citius Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	-	-	-	26.48	41.71	70.07
Cash & Short-Term Investments	-	-	-	26.48	41.71	70.07
Cash Growth	-	-	-	-36.51%	-40.47%	405.59%
Accounts Receivable	4.05	-	-	-	-	-
Inventory	22.64	22.29	8.27	-	-	-
Other Current Assets	3.54	1.4	2.7	7.89	2.85	2.74
Total Current Assets	30.22	23.68	10.97	34.37	44.56	72.81
Net Property, Plant & Equipment	0.84	0.82	0.25	0.46	0.65	0.83
Other Intangible Assets	92.23	92.8	92.8	59.4	59.4	59.4
Goodwill	9.35	9.35	9.35	9.35	9.35	9.35
Other Long-Term Assets	0.04	0.04	0.04	0.04	0.04	0.04
Total Assets	140.39	130.94	116.65	103.61	114	142.43
Accounts Payable	11.02	13.69	4.93	2.93	1.17	1.28
Accrued Expenses	7.79	7.48	2.25	2.63	3.17	2.53
Short-Term Debt	1	1	-	-	-	-
Current Portion of Leases	0.15	0.09	0.24	0.22	0.2	0.18
Other Current Liabilities	18.25	22.65	28.4	-	-	-
Total Current Liabilities	38.21	44.91	35.81	5.78	4.53	3.98
Long-Term Leases	0.68	0.72	0.02	0.26	0.48	0.68
Other Long-Term Liabilities	8.04	7.77	6.71	6.14	5.56	4.99
Total Long-Term Liabilities	8.72	8.5	6.74	6.4	6.04	5.66
Total Liabilities	46.92	53.41	42.55	12.18	10.57	9.65
Common Stock	0.02	0.02	0.01	0.01	0.15	0.15
Additional Paid-in Capital	326.96	306.34	271.44	253.06	232.37	228.08
Retained Earnings	-247.03	-238.8	-201.37	-162.23	-129.69	-96.05
Total Common Shareholders' Equity	79.96	67.55	70.08	90.83	102.83	132.18
Minority Interest	13.51	9.98	4.02	0.6	0.6	0.6
Shareholders' Equity	93.47	77.53	74.1	91.43	103.43	132.78
Total Liabilities & Equity	140.39	130.94	116.65	103.61	114	142.43
Total Debt	1.83	1.81	0.26	0.48	0.68	0.86
Net Cash (Debt)	-1.83	-1.81	-0.26	26	41.03	69.22
Net Cash Growth	-	-	-	-36.64%	-40.72%	453.40%
Net Cash Per Share	-0.07	-0.16	-0.04	4.30	7.02	15.93
Book Value	79.96	67.55	70.08	90.83	102.83	132.18
Book Value Per Share	2.82	6.10	10.41	15.01	17.60	30.43
Tangible Book Value	-21.62	-34.6	-32.07	22.08	34.08	63.44
Tangible Book Value Per Share	-0.76	-3.12	-4.76	3.65	5.83	14.60

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q